Why We Compare Instead of Recommend One Provider
Most ED sites online are actually a single provider's marketing page wearing a "review" or "comparison" costume. You've probably landed on a few without realizing it — a glowing writeup of exactly one company, followed by a big button to sign up with them. That's not what this site does, and it's worth explaining why.
The problem with picking a winner
Erectile dysfunction telehealth isn't a single decision with one right answer. Someone who's never tried treatment before has different needs than someone whose first medication didn't work. Someone who wants the absolute lowest starting cost is making a different tradeoff than someone who wants a provider built for long-term dose adjustment. A single "best overall" pick flattens all of that into one recommendation that's wrong for most of the people reading it.
What we do instead
- List what each provider actually specializes in, not just that they exist
- Flag when a medication is compounded rather than FDA-approved, every time
- Compare intake experience, not just price, since friction is often the real barrier to getting treated at all
- Update comparisons when a provider's offer or positioning changes, rather than leaving a stale writeup up indefinitely
Where we make money, plainly stated
We earn a commission if you visit a provider through a link on this site and end up becoming their customer. That's disclosed on every page, including this one. It doesn't change the price you pay, and it doesn't change which providers we list — we're not paid more to favor one over another in how we describe them. If a provider's model isn't a good fit for a particular reader's situation, we say so.
What this means for you
Use the comparisons on this site the way you'd use any honest reference: to understand what's actually different between your options, then make the call yourself based on what you're looking for. The clinical decision about whether treatment is appropriate for you is made by a licensed provider during your evaluation — not by us, and not by this page.